Identification of 12p as a region of frequent deletion in advanced prostate cancer

被引:0
|
作者
Kibel, AS
Schutte, M
Kern, SE
Isaacs, WB
Bova, GS
机构
[1] Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21287 USA
[2] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21287 USA
[3] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21287 USA
[4] Acad Hosp Rotterdam Dijkzigt, Rotterdam Canc Inst, Dept Med Oncol, Div Endocrine Oncol, Rotterdam, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The identification of homozygous deletions in malignant tissue has been a powerful tool for the localization of tumor suppressor genes, Representational difference analysis (RDA) uses selective hybridization and the PCR to isolate regions of chromosomal loss and has facilitated the identification of tumor suppressor genes such as BRCA2 and PTEN, Twenty RDA clones were generated by comparing genomic DNA from a prostate cancer xenograft to the same patient's normal kidney DNA, Southern blot analysis of the tester and driver and of normal and xenograft DNA, using the differential products as probes, showed the homozygous deletion in 16 of 20 RDA clones. The sequence of one of the differential products overlapped HSU59962, a genomic GenBank sequence on chromosome 12p12-13. Multiplex PCR of the xenograft DNA using polymorphic repeats mapped the deletion to a 1-5-cM region on 12p, Genomic DNA isolated from a panel of cryostat microdissected metastatic prostate adenocarcinomas/normal pairs was screened for loss of heterozygosity using the same polymorphic repeats, Loss of heterozygosity was demonstrated in 9 (47%) of 19 patients, This region may contain, or lie in close proximity to, tumor suppressor genes important in the progression and/or initiation of prostate cancer.
引用
收藏
页码:5652 / 5655
页数:4
相关论文
共 50 条
  • [41] Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer
    Kawana, Y
    Ichikawa, T
    Suzuki, H
    Ueda, T
    Komiya, A
    Ichikawa, Y
    Furuya, Y
    Akakura, K
    Igarashi, T
    Ito, H
    PROSTATE, 2002, 53 (01): : 60 - 64
  • [42] A 4.5 Mb terminal deletion of chromosome 12p helps further define a psychosis-associated locus
    Vargas, Hilda
    Beldia, Gail
    Korosh, William
    Sudhalter, Vicki
    Iqbal, Anwar
    Sanchez-Lacay, Jose Arturo
    Velinov, Milen
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2012, 55 (10) : 573 - 576
  • [43] TEL is the target for deletion on 12p in many cases of childhood B-lineage acute lymphoblastic leukemia
    Takeuchi, S
    Seriu, T
    Bartram, CR
    Golub, TR
    Reiter, A
    Miyoshi, I
    Gilliland, DG
    Koeffler, HP
    BLOOD, 1996, 88 (10) : 247 - 247
  • [44] Genetic predisposition to familial neuroblastoma: Identification of two novel genomic regions at 2p and 12p
    Longo, Luca
    Panza, Emanuele
    Schena, Francesca
    Seri, Marco
    Devoto, Marcella
    Romeo, Giovanni
    Bini, Carla
    Pappalardo, Giuseppe
    Tonini, Gian Paolo
    Perri, Patrizia
    HUMAN HEREDITY, 2007, 63 (3-4) : 205 - 211
  • [45] Infant with a duplication of 12p and a deletion of 18q resulting from mother's t(12;18) balanced translocation
    Letica, Ljiljana
    Lasan, Ruzica
    Omerza, Lana
    Gornik, Kristina Crkvenac
    Durisevic, Ivana Tonkovic
    Begovic, Davor
    CHROMOSOME RESEARCH, 2011, 19 : S116 - S116
  • [46] Deletion in a regulatory region is associated with underexpression of miR-148b-3p in patients with prostate cancer
    Bergez-Hernandez, Fernando
    Luque-Ortega, Fred
    Garcia-Magallanes, Noemi
    Alvarez-Arrazola, Marco
    Arambula-Meraz, Eliakym
    BIOMEDICAL REPORTS, 2024, 20 (03)
  • [47] TETRASOMY 12P AND BURKITT'S LYMPHOMA: CANCER IN PALLISTER-KILLIAN SYNDROME?
    Ganetzky, Rebecca D.
    Wertheim, Gerald B. W.
    Wilkens, Alisha
    Fincher, Christopher
    Wilmoth, Donna
    Biegel, Jaclyn A.
    Bagatell, Rochelle
    Nichols, Susan R. E.
    Conlin, Laura
    Deardorff, Matthew A.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2015, 167 (08) : 1700 - 1701
  • [48] Prenatal diagnosis of the Dandy-Walker malformation and ventriculomegaly associated with partial trisomy 9p and distal 12p deletion
    Chen, CP
    Chang, TY
    Shih, JC
    Lin, SP
    Lin, CJ
    Wang, WS
    Lee, CC
    Town, DD
    Pan, CW
    Tzen, CY
    PRENATAL DIAGNOSIS, 2002, 22 (12) : 1063 - 1066
  • [49] Expression mapping at 12p12-13 in advanced prostate carcinoma
    Kibel, AS
    Huagen, J
    Guo, C
    Isaacs, WB
    Yan, Y
    Pienta, KJ
    Goodfellow, PJ
    INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (05) : 668 - 672
  • [50] Expression mapping at 12p12-13 in advanced prostate carcinoma
    Kibel, AS
    Hurt, N
    Guo, C
    Pienta, KJ
    Goodfellow, PJ
    JOURNAL OF UROLOGY, 2003, 169 (04): : 82 - 82